Screening two mutations in the dysferlin gene by exon capture and sequence analysis: A case report

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Progressive muscular atrophy is a debilitating neuromuscular disorder.
• Genetic factors play a significant role in the etiology of various neuromuscular disorders.
• Accurate genetic diagnosis is crucial for understanding disease mechanisms and potential treatments.

Purpose of the Study:

• To identify disease-associated genes in a patient with progressive muscular atrophy using advanced sequencing technologies.
• To characterize novel genetic mutations contributing to neuromuscular disorders.
• To evaluate the efficacy of exon capture and sequence analysis for genetic screening in neuromuscular conditions.

Main Methods:

• Next-generation sequencing (NGS) and exon trap analysis were employed to screen for genetic alterations.
• A comprehensive gene panel covering 659 types of neuromuscular disorders was utilized.
• Sanger sequencing was used to confirm identified mutations in the dysferlin (DYSF) gene.

Main Results:

• NGS identified 399 relevant genes, including all exons and flanking regions.
• Two novel splice site mutations, c.144+1G>A and c.342+1G>T, were discovered in the patient's DYSF gene.
• Familial analysis confirmed the inheritance of these DYSF gene mutations in the patient's mother and sister.

Conclusions:

• Exon capture and sequence analysis provide a rapid and efficient method for screening genetic alterations in neuromuscular disorders.
• The identification of novel DYSF gene mutations expands the known mutational spectrum for dysferlinopathies.
• This study highlights the utility of advanced genetic technologies in diagnosing complex neuromuscular conditions.